Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 02:40PM EDT. Market open.
| Previous Close | 418.99 |
| Open | 420.40 |
| Bid | 421.86 x 100 |
| Ask | 422.86 x 100 |
| Day's Range | 417.50 - 422.23 |
| 52 Week Range | 320.01 - 448.40 |
| Volume | |
| Avg. Volume | 1,042,100 |
| Market Cap | 108.941B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 27.38 |
| EPS (TTM) | 15.42 |
| Earnings Date | Jul 30, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 466.90 |
GuruFocus.comAlpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
Simply Wall St.Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
© 2024 Yahoo. All rights reserved.